Enteric diseases are intestinal infections are occurred due to parasites, bacteria, and viruses once it enters the body by oral or digestive tracts such as Vibrio cholera, campylobacter, shigella, salmonella, giardia lamblia, cryptosporidium, and it causes cholera, campylobacteriosis, shigellosis, salmonellosis, giardiasis, and cryptosporidiosis respectively.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1164
By the end of 2027, the global enteric disease testing market is expected to be worth US$ 4,432.7 million.
Global Enteric Disease Testing Market: Drivers
Over the forecast period, the global enteric disease testing market is expected to grow due to the high prevalence of cholera. For instance, since the commencement of 2019, severe rains and floods in Yemen have caused around 364,000 probable cholera cases and around 639 fatalities, according to the UN High Commissioner for Refugees.
Furthermore, an enteric disease outbreak is expected to increase the supply for enteric disease testing. For instance, a salmonella outbreak in August 2020, was recorded in around 47 states across the U.S. In the third week of August, the Centers for Disease Control and Prevention (CDC) stated that the Salmonella Newport cases had risen to 869, with 116 hospitalized patients in around 47 states.
In 2019, North America accounted for the largest share in the global enteric disease testing market, holding around 38.5% of the market value, trailed by Europe and the Asia Pacific.
Global Enteric Disease Testing Market: Restraints
The global enteric disease testing market is expected to be restrained by a lack of knowledge about the enteric disease, particularly in emerging nations over the forecast period.
Furthermore, the majority of persons who are diseased with enteric pathogens are asymptomatic. The mild form of diseases allows individuals to neglect their diagnosis. Although the mild form of enteric diseases is beneficial to humans, it is also one of the key factors restricting the global enteric disease testing market growth over the forecast period.
Global Enteric Disease Testing Market: Opportunities
The development of bovine enteric diseases vaccines is expected to provide attractive growth prospects for companies in the global enteric disease testing market during the forecast period. Diarrhea in calves can be deadly. Autogenous vaccinations may be useful if commercial vaccines fail to treat the scours.
Furthermore, enteric disease research and development is expected to increase the demand for enteric disease testing. For instance, studies conducted by Emory University in the U.S and Bangladesh’s International Centre for Diarrheal Disease Research observed large traces of pathogens such as Shigella, giardia, Salmonella typhi, norovirus, E. coli, and Vibrio cholera, in Bangladesh between April 2017-January 2018 and April 2019-October 2019.
In 2019 the global enteric disease testing market was worth US$ 3,643.4 Million and is expected to reach US$ 4,432.7 Million at a CAGR of 2.5% over the forecast period 2020 – 2027.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/1164
Market Trends/Key Takeaways
Key market players are concentrating on the approval and release of novel products in order to increase their product line. Mobidiag Ltd., a molecular diagnostics company, obtained CE marking for their Novodiag Stool Parasites test in October 2019. The new technique is used to identify intestinal parasites in stool samples directly.
The global enteric disease testing market is expected to grow in response to the campylobacter infection outbreak. for instance, Lindsay Farm in New Zealand revoked the raw drinking milk in August 2020 after a person was hospitalized for Campylobacter disease.
Global Enteric Disease Testing Market: Competitive Landscape
Some of the key players contributing to the global enteric disease testing market are Quest Diagnostics, Biomerica, Inc., DiaSorin, Becton Dickinson & Co., Meridian Bioscience, Inc., Bio-Rad, Trinity Biotech, Cepheid, bioMerieux, Coris BioConcept, and Alere, Inc.
Global Enteric Disease Testing Market: Key Developments
key players of the global enteric disease testing market are concentrating on getting new products approved and launched to increase their product line. For instance, ERADA Technology Alliance Ltd. introduced the Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART), a saliva-based diagnostic tool for detecting parasites that cause malaria in March 2019.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027